These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 8419833)

  • 1. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 2. Health policy report. Funding the End-Stage Renal-Disease Program.
    Iglehart JK
    N Engl J Med; 1982 Feb; 306(8):492-6. PubMed ID: 7035954
    [No Abstract]   [Full Text] [Related]  

  • 3. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH; Sapolsky HM
    Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helping patients with end-stage renal disease.
    Kuchta K; VanBuskirk S; Houglum M
    Am J Nurs; 2007 May; 107(5):35-6. PubMed ID: 17443073
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace.
    Lowrie EG; Hampers CL
    N Engl J Med; 1981 Aug; 305(8):434-8. PubMed ID: 7019710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation and the end-stage renal disease program.
    Heitman J
    Pharos Alpha Omega Alpha Honor Med Soc; 1993; 56(1):2-8. PubMed ID: 8434036
    [No Abstract]   [Full Text] [Related]  

  • 9. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG
    N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract]   [Full Text] [Related]  

  • 10. End stage renal disease--the end of the road.
    Rao M
    Natl Med J India; 1992; 5(5):241-3. PubMed ID: 1302587
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicare program; End Stage Renal Disease Program; responsibilities of network organizations--HCFA. Final rule.
    Fed Regist; 1988 Jan; 53(13):1617-20. PubMed ID: 10302132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Justice and cost-containment in end-stage renal disease.
    Johnstone BV
    J Contemp Health Law Policy; 1987; 3():65-84. PubMed ID: 10301637
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
    Garg PP; Frick KD; Diener-West M; Powe NR
    N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider-patient relations and treatment choice in the era of fiscal incentives: the case of the end-stage renal disease program.
    Bovbjerg RR; Held PJ; Diamond LH
    Milbank Q; 1987; 65(2):177-202. PubMed ID: 3614141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transplantation on the Medicare end-stage renal disease program.
    Eggers PW
    N Engl J Med; 1988 Jan; 318(4):223-9. PubMed ID: 3275896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The politics of health cost containment: end-stage renal disease.
    Rettig RA
    Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928
    [No Abstract]   [Full Text] [Related]  

  • 17. Extension of Medicare immunosuppressive drug benefits: a "no brainer" that did not happen.
    Bennett WM
    Clin J Am Soc Nephrol; 2010 May; 5(5):743. PubMed ID: 20448072
    [No Abstract]   [Full Text] [Related]  

  • 18. The changing tide in ESRD care.
    Sullivan JD
    Nephrol News Issues; 2010 Jul; 24(8):24, 27-8. PubMed ID: 20695319
    [No Abstract]   [Full Text] [Related]  

  • 19. The Medicare end-stage renal disease program. A report from the Institute of Medicine.
    Levinsky NG; Rettig RA
    N Engl J Med; 1991 Apr; 324(16):1143-8. PubMed ID: 2008193
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare program: End-Stage Renal Disease program; revised network area designations--HCFA. Final rule.
    Fed Regist; 1987 Oct; 52(191):37018-25. PubMed ID: 10301901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.